Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin

Deh Wei Tang, Shu Huei Yu, Yi Cheng Ho, Fwu Long Mi, Pi Li Kuo, Hsing Wen Sung

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

To improve blood supply following ischemic injury, angiogenic factors such as fibroblast growth factor (bFGF) that stimulate new blood vessel formation have been used for therapeutic angiogenesis in3 ischemic tissues. In this study, heparin-functionalized chitosan (CS)/poly(γ-glutamic acid) (γ-PGA) nanoparticles (HP-CS/γ-PGA nanoparticles) were prepared for multi-functional delivery of basic fibroblast growth factor (bFGF) and heparin. The mean particle sizes and bFGF loading efficiency increased with the increase of functionalized heparin contents. The HP-CS/γ-PGA nanoparticles were pH-sensitive that could sustain bFGF release at pH ? 6.7 (simulate the pH of ischemia tissue) and were rapidly disintegrated at pH 7.4 (simulate the pH of repaired tissue). Sustained release of bFGF from the nanoparticles enhanced the proliferation of human foreskin fibroblast cells (HFF) and angiogenic tube formation by human umbilical vein endothelial cells (HUVEC), suggesting the retaining of bFGF mitogenic activity. Heparin, a traditionally used anticoagulant, could release from the disintegrated nanoparticles to maintain the anti-factor Xa activity in blood plasma, after increasing the pH value from 6.6 to 7.4. The nanocarriers for mutil-functional delivery of bFGF and heparin developed in this study may be a potential therapeutic method for enhancing ischemic tissue regeneration and preventing blood vessel rethrombosis.

Original languageEnglish
Pages (from-to)9320-9332
Number of pages13
JournalBiomaterials
Volume31
Issue number35
DOIs
Publication statusPublished - Dec 2010
Externally publishedYes

Fingerprint

Fibroblast Growth Factors
Chitosan
Fibroblast Growth Factor 2
Fibroblasts
Nanoparticles
Heparin
Glutamic Acid
Acids
Prostaglandins A
Blood vessels
Tissue
Blood Vessels
Blood
Foreskin
Tissue regeneration
Factor Xa
Angiogenesis Inducing Agents
Endothelial cells
Human Umbilical Vein Endothelial Cells
Intercellular Signaling Peptides and Proteins

Keywords

  • γ-PGA
  • BFGF
  • Chitosan
  • Heparin-functionalized
  • Nanoparticles

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. / Tang, Deh Wei; Yu, Shu Huei; Ho, Yi Cheng; Mi, Fwu Long; Kuo, Pi Li; Sung, Hsing Wen.

In: Biomaterials, Vol. 31, No. 35, 12.2010, p. 9320-9332.

Research output: Contribution to journalArticle

Tang, Deh Wei ; Yu, Shu Huei ; Ho, Yi Cheng ; Mi, Fwu Long ; Kuo, Pi Li ; Sung, Hsing Wen. / Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. In: Biomaterials. 2010 ; Vol. 31, No. 35. pp. 9320-9332.
@article{f5bb1bd2ef1e4592b15ab37eefdb4860,
title = "Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin",
abstract = "To improve blood supply following ischemic injury, angiogenic factors such as fibroblast growth factor (bFGF) that stimulate new blood vessel formation have been used for therapeutic angiogenesis in3 ischemic tissues. In this study, heparin-functionalized chitosan (CS)/poly(γ-glutamic acid) (γ-PGA) nanoparticles (HP-CS/γ-PGA nanoparticles) were prepared for multi-functional delivery of basic fibroblast growth factor (bFGF) and heparin. The mean particle sizes and bFGF loading efficiency increased with the increase of functionalized heparin contents. The HP-CS/γ-PGA nanoparticles were pH-sensitive that could sustain bFGF release at pH ? 6.7 (simulate the pH of ischemia tissue) and were rapidly disintegrated at pH 7.4 (simulate the pH of repaired tissue). Sustained release of bFGF from the nanoparticles enhanced the proliferation of human foreskin fibroblast cells (HFF) and angiogenic tube formation by human umbilical vein endothelial cells (HUVEC), suggesting the retaining of bFGF mitogenic activity. Heparin, a traditionally used anticoagulant, could release from the disintegrated nanoparticles to maintain the anti-factor Xa activity in blood plasma, after increasing the pH value from 6.6 to 7.4. The nanocarriers for mutil-functional delivery of bFGF and heparin developed in this study may be a potential therapeutic method for enhancing ischemic tissue regeneration and preventing blood vessel rethrombosis.",
keywords = "γ-PGA, BFGF, Chitosan, Heparin-functionalized, Nanoparticles",
author = "Tang, {Deh Wei} and Yu, {Shu Huei} and Ho, {Yi Cheng} and Mi, {Fwu Long} and Kuo, {Pi Li} and Sung, {Hsing Wen}",
year = "2010",
month = "12",
doi = "10.1016/j.biomaterials.2010.08.058",
language = "English",
volume = "31",
pages = "9320--9332",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier Science Ltd",
number = "35",

}

TY - JOUR

T1 - Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin

AU - Tang, Deh Wei

AU - Yu, Shu Huei

AU - Ho, Yi Cheng

AU - Mi, Fwu Long

AU - Kuo, Pi Li

AU - Sung, Hsing Wen

PY - 2010/12

Y1 - 2010/12

N2 - To improve blood supply following ischemic injury, angiogenic factors such as fibroblast growth factor (bFGF) that stimulate new blood vessel formation have been used for therapeutic angiogenesis in3 ischemic tissues. In this study, heparin-functionalized chitosan (CS)/poly(γ-glutamic acid) (γ-PGA) nanoparticles (HP-CS/γ-PGA nanoparticles) were prepared for multi-functional delivery of basic fibroblast growth factor (bFGF) and heparin. The mean particle sizes and bFGF loading efficiency increased with the increase of functionalized heparin contents. The HP-CS/γ-PGA nanoparticles were pH-sensitive that could sustain bFGF release at pH ? 6.7 (simulate the pH of ischemia tissue) and were rapidly disintegrated at pH 7.4 (simulate the pH of repaired tissue). Sustained release of bFGF from the nanoparticles enhanced the proliferation of human foreskin fibroblast cells (HFF) and angiogenic tube formation by human umbilical vein endothelial cells (HUVEC), suggesting the retaining of bFGF mitogenic activity. Heparin, a traditionally used anticoagulant, could release from the disintegrated nanoparticles to maintain the anti-factor Xa activity in blood plasma, after increasing the pH value from 6.6 to 7.4. The nanocarriers for mutil-functional delivery of bFGF and heparin developed in this study may be a potential therapeutic method for enhancing ischemic tissue regeneration and preventing blood vessel rethrombosis.

AB - To improve blood supply following ischemic injury, angiogenic factors such as fibroblast growth factor (bFGF) that stimulate new blood vessel formation have been used for therapeutic angiogenesis in3 ischemic tissues. In this study, heparin-functionalized chitosan (CS)/poly(γ-glutamic acid) (γ-PGA) nanoparticles (HP-CS/γ-PGA nanoparticles) were prepared for multi-functional delivery of basic fibroblast growth factor (bFGF) and heparin. The mean particle sizes and bFGF loading efficiency increased with the increase of functionalized heparin contents. The HP-CS/γ-PGA nanoparticles were pH-sensitive that could sustain bFGF release at pH ? 6.7 (simulate the pH of ischemia tissue) and were rapidly disintegrated at pH 7.4 (simulate the pH of repaired tissue). Sustained release of bFGF from the nanoparticles enhanced the proliferation of human foreskin fibroblast cells (HFF) and angiogenic tube formation by human umbilical vein endothelial cells (HUVEC), suggesting the retaining of bFGF mitogenic activity. Heparin, a traditionally used anticoagulant, could release from the disintegrated nanoparticles to maintain the anti-factor Xa activity in blood plasma, after increasing the pH value from 6.6 to 7.4. The nanocarriers for mutil-functional delivery of bFGF and heparin developed in this study may be a potential therapeutic method for enhancing ischemic tissue regeneration and preventing blood vessel rethrombosis.

KW - γ-PGA

KW - BFGF

KW - Chitosan

KW - Heparin-functionalized

KW - Nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=77957949816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957949816&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2010.08.058

DO - 10.1016/j.biomaterials.2010.08.058

M3 - Article

VL - 31

SP - 9320

EP - 9332

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 35

ER -